
#40 – Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant
Details
In This Episode We Discuss: Clinical Trial Feasibility
Join us on the latest episode! Our Guests: Christine Senn, PhD, SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.
What you'll get out of this episode:
- Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.
- Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.
- The need for diverse site participation and data inputs to improve trial accuracy and efficiency.
- The role of AI and technology in enhancing clinical trial processes.
Watch
Listen